QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BLCO

QT62Bausch + Lomb Corporation
NYSE·Healthcare·Medical - Instruments & Supplies·Canada
Latest market price
14.87
+0.01+0.07%
OverviewShort InterestFilings
BLCOQT62Bausch + Lomb Corporation·NYSE
OverviewShort InterestFilings
14.87+0.07%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-0.62
Insider Own-
Shs Outstand356.57M
Perf Week-2.75%
Market Cap5.30BForward P/E13.85EPS next Y1.07Insider Trans0.02%Shs Float-Perf Month-8.21%
Enterprise Value10.10BPEG-EPS next Q0.16Inst Own-Short Float-Perf Quarter-8.04%
Income-219872402.00P/S1.02EPS this Y230.00%Inst Trans-Short Ratio-Perf Half Y-12.43%
Sales5.21BP/B0.83EPS next Y33.20%ROA-1.59%Short Interest-Perf YTD-12.94%
Book/sh18.09P/C15.51EPS next 5Y30.22%ROE-3.41%52W High18.92 -21.41%Perf Year28.41%
Cash/sh0.75P/FCF1223.79EPS past 3/5Y-ROIC2.57%52W Low11.44 29.98%Perf 3Y-
Dividend Est.-EV/EBITDA15.56Sales past 3/5Y10.62% 8.38%Gross Margin55.86%Volatility1.57% 1.66%Perf 5Y-
Dividend TTM-EV/Sales1.94EPS Y/Y TTM172.22%Oper. Margin5.91%ATR (14)0.40Perf 10Y-
Dividend Ex-Date-Quick Ratio0.99Sales Y/Y TTM8.70%Profit Margin-4.21%RSI (14)37.02Recom2.71
Dividend Gr. 3/5Y-Current Ratio1.53EPS Q/Q214.29%SMA20-3.14%Beta1.09Target Price18.57
Payout0.00%Debt/Eq0.79Sales Q/Q9.41%SMA50-6.22%Rel Volume0.73Prev Close14.86
Employees13,500LT Debt/Eq0.81EarningsJul 29SMA200-7.86%Avg Volume459.31KPrice14.87
IPO DateMay 06, 2022Option/ShortYes / YesEPS/Sales Surpr.33.33% 2.30%Net Debt/EBITDA7.40Volume334,168Change0.07%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-30-26ReiteratedDeutsche BankHold$18 → $16
Feb-23-26ReiteratedH.C. Wainwright$17 → $20
Feb-19-26ReiteratedStifel Nicolaus$15 → $16
Feb-19-26ReiteratedDeutsche BankHold$15 → $18
Feb-19-26ReiteratedBarclaysEqual Weight$17 → $20
Feb-17-26ReiteratedStifel Nicolaus$14 → $15
Jan-27-26ReiteratedRBC CapitalOutperform$19 → $21
Jan-09-26ReiteratedGoldman SachsNeutral$17 → $19
Jan-05-26ReiteratedEvercore ISI$25 → $18
Jan-05-26DowngradeEvercore ISI GroupOutperform → In Line
Latest News
Jun-10-26
Jun-10-2610:36AM
Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?Yahoo
10:00AM
Bausch + Lomb to lay off employees in MissouriYahoo
09:12AM
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue5,2085,1014,791
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,2992,3081,872
Gross Profit2,9092,7932,919
Selling, General and Administrative Excl. Other2,2152,2342,082
Research and Development386371343
Other Operating Expense00332
Operating Income308188162
Interest Expense434431399
Unusual Expense
———
Non-Operating Income (Expense)7574-3
Net Income Before Taxes-201-317-234
Income Taxes103571
Consolidated Net Income-219-360-317
Net Income From Continuing Operations-211-352-305
Net Income-219-360-317
EPS (Recurring)-0.62-1.02-0.90
EPS (Basic, Before Extraordinaries)-0.62-1.02-0.90
EPS (Diluted)-0.62-1.02-0.90
EBITDA649535601
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.011.19—
Gross Margin55.8654.7560.93
Operating Margin5.913.693.38
Net Margin-4.21-7.06-6.62
Shares Outstanding355354352
Market Capitalization5,2796,046—
Operating Lease Expense
———
Insider Trading Volume
$15.93$14.84$13.75$12.67$11.58● Close Price0.00K181.83K363.67K545.50K727.34KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bailey A Robert DEVP & Chief Legal OfficerMar 06 '26Buy17.1514,600250,332231,890Mar 10 12:00 AM
Eldessouky SamEVP and CFOMar 06 '26Buy17.134,00068,520403,130Mar 10 12:00 AM
SAUNDERS BRENT LCEO and Chairman of the BoardMar 06 '26Buy17.1414,700251,958966,575Mar 10 12:00 AM
Ross Thomas W. Sr.DirectorMar 03 '26Buy17.684,50079,55664,891Mar 04 12:00 AM
Alfonso EduardoDirectorMar 02 '26Buy17.904,30076,9709,555Mar 03 12:00 AM
VON ESCHENBACH ANDREW C.DirectorFeb 27 '26Buy18.304,36479,88366,450Mar 03 12:00 AM
COLLIS STEVEN HDirectorFeb 23 '26Buy17.8115,000267,15020,255Feb 24 12:00 AM
ROBERTSON RUSSEL CDirectorFeb 20 '26Buy17.904,40078,76072,407Feb 24 12:00 AM
Ling KarenDirectorFeb 19 '26Buy17.744,00070,96841,676Feb 23 12:00 AM
SAUNDERS BRENT LCEO and Chairman of the BoardMay 22 '25Buy11.2822,000248,072719,156May 27 12:00 AM
VON ESCHENBACH ANDREW C.DirectorMay 02 '25Buy11.761,69519,92541,748May 06 12:00 AM
SAUNDERS BRENT LCEO and Chairman of the BoardAug 05 '24Buy15.6632,250505,067595,169Aug 07 12:00 AM
Bausch Health Companies Inc.director:Jun 01 '22Sale17.054,550,35777,606,339310,449,643Jun 02 12:00 AM
Bausch Health Companies Inc.director:May 10 '22Sale17.0535,000,000596,925,000315,000,000May 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR